For: | Tonini V, Zanni M. Pancreatic cancer in 2021: What you need to know to win. World J Gastroenterol 2021; 27(35): 5851-5889 [PMID: 34629806 DOI: 10.3748/wjg.v27.i35.5851] |
---|---|
URL: | https://www.wjgnet.com/2218-6190/full/v27/i35/5851.htm |
Number | Citing Articles |
1 |
Ramya Devi KT, Dharshene Karthick, Kirtikesav Salem Saravanaraj, M. K. Jaganathan, Suvankar Ghorai, Sanjana Prakash Hemdev. The Roles of MicroRNA in Pancreatic Cancer Progression. Cancer Investigation 2022; 40(8): 700 doi: 10.1080/07357907.2022.2057526
|
2 |
Huaqing Shi, Zhou Chen, Shi Dong, Ru He, Yan Du, Zishun Qin, Wence Zhou. A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02362-2
|
3 |
Huijie Zhao, Huiyang Liu, Yihan Yang, Honggang Wang. The Emerging Role of EVA1A in Different Types of Cancers. International Journal of Molecular Sciences 2022; 23(12): 6665 doi: 10.3390/ijms23126665
|
4 |
Lina Zheng, Hailiang Liu. Prognostic association between NLRP3 inflammasome expression level and operable pancreatic adenocarcinoma. The International Journal of Biological Markers 2022; 37(3): 314 doi: 10.1177/03936155221096690
|
5 |
Jing Wang, Liping Zheng, Chundong Hu, Demiao Kong, Zhongcheng Zhou, Bin Wu, Shaohan Wu, Famin Fei, Yiyu Shen. CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein. Cellular Signalling 2023; : 110661 doi: 10.1016/j.cellsig.2023.110661
|
6 |
Miguel A. Ortega, Oscar Fraile-Martinez, Leonel Pekarek, Cielo García-Montero, Miguel Angel Alvarez-Mon, Alejandro J. Castellanos, Natalio García-Honduvilla, Julia Buján, Melchor Alvarez-Mon, Miguel A. Sáez, Luis G. Guijarro, Angel Asúnsolo. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer. Antioxidants 2022; 11(4): 759 doi: 10.3390/antiox11040759
|
7 |
Hrvoje Kaučić, Domagoj Kosmina, Dragan Schwarz, Andreas Mack, Hrvoje Šobat, Adlan Čehobašić, Vanda Leipold, Iva Andrašek, Asmir Avdičević, Mihaela Mlinarić. Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study. Cancers 2022; 14(11): 2688 doi: 10.3390/cancers14112688
|
8 |
Basil N Nduma, Solomon Ambe, Chukwuyem Ekhator, Ekokobe Fonkem. Geographical Distribution of Pancreatic Cancer in the State of Mississippi by Incidence and Mortality From 2003 to 2019. Cureus 2022; doi: 10.7759/cureus.31605
|
9 |
Guoxiao Zhang, Bo Li, Xiaoyi Yin, Suizhi Gao, Shuo Shen, Huan Wang, Xiaohan Shi, Wuchao Liu, Kailian Zheng, Wei Jing, Yijie Zhang, Tianlin He, Gang Li, Xiangui Hu, Shiwei Guo, Gang Jin. Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases. International Journal of Surgery 2022; 104: 106786 doi: 10.1016/j.ijsu.2022.106786
|
10 |
Xingren Guo, Xiangyang Song, Xiaoyin Long, Yahui Liu, Yixin Xie, Cheng Xie, Bai Ji. New nomogram for predicting lymph node positivity in pancreatic head cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1053375
|
11 |
Sergio Pedrazzoli. Surgical treatment of pancreatic cancer: Currently debated topics on morbidity, mortality, and lymphadenectomy. Surgical Oncology 2022; 45: 101858 doi: 10.1016/j.suronc.2022.101858
|
12 |
Kévin Toussaint, Aline Appert-Collin, Hamid Morjani, Camille Albrecht, Hervé Sartelet, Béatrice Romier-Crouzet, Pascal Maurice, Laurent Duca, Sébastien Blaise, Amar Bennasroune. Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases. Cancers 2022; 14(19): 4868 doi: 10.3390/cancers14194868
|
13 |
Shanshi Tong, Zhilong Yu, Fang Yin, Qilin Yang, Juhang Chu, Luyao Huang, Wenxue Gao, Mingping Qian. Manganese-based Prussian blue nanoparticles inhibit tumor proliferation and migration via the MAPK pathway in pancreatic cancer. Frontiers in Chemistry 2022; 10 doi: 10.3389/fchem.2022.1026924
|
14 |
Heidelinde Sammallahti, Virinder Kaur Sarhadi, Arto Kokkola, Reza Ghanbari, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Pauli Puolakkainen, Sakari Knuutila. Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool. Biomolecules 2022; 12(5): 652 doi: 10.3390/biom12050652
|
15 |
Albert W. Girotti, Jonathan F. Fahey, Witold Korytowski. Role of nitric oxide in hyper-aggressiveness of tumor cells that survive various anti-cancer therapies. Critical Reviews in Oncology/Hematology 2022; 179: 103805 doi: 10.1016/j.critrevonc.2022.103805
|
16 |
Liwen Fan, Xinyu Wang, Qing Chang, Yue Wang, Wenjie Yang, Linlin Liu. IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma. Medicine 2022; 101(42): e30966 doi: 10.1097/MD.0000000000030966
|
17 |
Keiji Nagata, Masatoshi Kajiwara, Takahisa Fujikawa. Long-Term Survival of a Patient With Peritoneal Carcinomatosis From Pancreatic Cancer Maintained by Nanoliposomal Irinotecan as Third-Line Chemotherapy. Cureus 2022; doi: 10.7759/cureus.22355
|
18 |
Niccolò Surci, Christiane Sophie Rösch, Patrick Kirchweger, Lukas Havranek, Paul von Boetticher, Ines Fischer, Helwig Valentin Wundsam, Matthias Biebl, Reinhold Függer. The Rate of Avoidable Pancreatic Resections at a High-Volume Center: An Internal Quality Control and Critical Review. Journal of Clinical Medicine 2023; 12(4): 1625 doi: 10.3390/jcm12041625
|